NCT05193019View on ClinicalTrials.gov

Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
Ischemic Heart DiseaseAcute Coronary Syndrome
Interventions
OTHER

Parenteral antiplatelet agents

Patients undergoing PCI and receiving parenteral antiplatelet agents, cangrelor or glycoprotein IIb/IIIa inhibitors (GPIs), during the procedure as per clinical practice

Trial Locations (12)

15706

RECRUITING

Hospital Clinico Universitario Santiago de Compostela, Santiago de Compostela

24080

RECRUITING

H.de Leon, León

28047

RECRUITING

Hospital Central de La Defensa Gómez Ulla, Madrid

31008

RECRUITING

Hospital Universitario de Navarra, Pamplona

33394

RECRUITING

Hospital Universitario de Cabueñes, Gijón

37007

RECRUITING

Hospital Clinico Universitario de Salamanca, Salamanca

39008

RECRUITING

Hospital Universitario Marques de Valdecilla, Santander

43005

RECRUITING

Hospital Universitari Joan Xxiii, Tarragona

48903

RECRUITING

Hospital Universitario de Cruces, Barakaldo

48960

RECRUITING

Hospital de Galdakao, Galdakao

50009

RECRUITING

Hospital Universitario Lozano Blesa, Zaragoza

08907

RECRUITING

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Fundación EPIC

OTHER